Identification and expression of a nuclear antigen from the genomic region of the Jijoye strain of Epstein-Barr virus that is missing in its nonimmortalizing deletion mutant, P3HR-1
- PMID: 2997790
- PMCID: PMC391358
- DOI: 10.1073/pnas.82.21.7429
Identification and expression of a nuclear antigen from the genomic region of the Jijoye strain of Epstein-Barr virus that is missing in its nonimmortalizing deletion mutant, P3HR-1
Abstract
An Epstein-Barr virus (EBV) deletion mutant, HR-1, cannot immortalize lymphocytes. HR-1 was derived from a virus strain, Jijoye, that is immortalization competent. Using human antiserum from certain patients with chronic active EBV infection, we have identified in Jijoye cells a protein of apparent mass of 78-80 kDa that is missing in cells with the HR-1 genome. A protein of identical size and antigenicity has been stably expressed in mouse LTK- cells by gene transfer with cloned Jijoye EBV DNA that encompasses the deletion in the HR-1 genome. The expressed product is a nuclear neoantigen. The polypeptide we have identified is likely to be essential in the immortalization process.
Similar articles
-
Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus.J Virol. 1989 Apr;63(4):1531-9. doi: 10.1128/JVI.63.4.1531-1539.1989. J Virol. 1989. PMID: 2538644 Free PMC article.
-
An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines.Proc Natl Acad Sci U S A. 1986 Sep;83(17):6641-5. doi: 10.1073/pnas.83.17.6641. Proc Natl Acad Sci U S A. 1986. PMID: 3018741 Free PMC article.
-
Deletion of the nontransforming Epstein-Barr virus strain P3HR-1 causes fusion of the large internal repeat to the DSL region.J Virol. 1982 Sep;43(3):952-68. doi: 10.1128/JVI.43.3.952-968.1982. J Virol. 1982. PMID: 6292473 Free PMC article.
-
Epstein-Barr virus in B lymphocytes: viral gene expression and function in latency.Adv Cancer Res. 1992;58:1-26. doi: 10.1016/s0065-230x(08)60288-2. Adv Cancer Res. 1992. PMID: 1312289 Review. No abstract available.
-
Epstein-Barr virus (EBV), lymphocytes and transformation.J Cancer Res Clin Oncol. 1983;106(1):1-11. doi: 10.1007/BF00399890. J Cancer Res Clin Oncol. 1983. PMID: 6309856 Review. No abstract available.
Cited by
-
Identification of the Epstein-Barr virus terminal protein gene products in latently infected lymphocytes.J Virol. 1990 Jun;64(6):2866-75. doi: 10.1128/JVI.64.6.2866-2875.1990. J Virol. 1990. PMID: 2159547 Free PMC article.
-
Genome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency.Proc Natl Acad Sci U S A. 1988 Dec;85(24):9801-5. doi: 10.1073/pnas.85.24.9801. Proc Natl Acad Sci U S A. 1988. PMID: 2849118 Free PMC article.
-
Epstein-Barr-Virus-Driven Cardiolipin Synthesis Sustains Metabolic Remodeling During B-cell Lymphomagenesis.Res Sq [Preprint]. 2024 Apr 8:rs.3.rs-4013392. doi: 10.21203/rs.3.rs-4013392/v1. Res Sq. 2024. Update in: Sci Adv. 2025 Jan 31;11(5):eadr8837. doi: 10.1126/sciadv.adr8837. PMID: 38659762 Free PMC article. Updated. Preprint.
-
Expression of the Epstein-Barr virus nuclear protein 2 in rodent cells.J Virol. 1986 Aug;59(2):453-62. doi: 10.1128/JVI.59.2.453-462.1986. J Virol. 1986. PMID: 2426468 Free PMC article.
-
Deletion mutants that affect expression of Epstein-Barr virus nuclear antigen in COS-1 cells after gene transfer with simian virus 40 vectors containing portions of the BamHI K fragment.J Virol. 1986 May;58(2):324-30. doi: 10.1128/JVI.58.2.324-330.1986. J Virol. 1986. PMID: 3009849 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources